Medigene AG (MDG1) — Cash Flow Reinvestment Rate
Latest as of June 2022:
0.01x
Medigene AG (MDG1) has a Cash Flow Reinvestment Rate of 0.01x as of June 2022, reinvesting €230.00K (capex €230.00K ) from operating cash flow of €17.30 Million. See MDG1 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.01x
(Capex + Investments) / Operating CF
Total Reinvested
€230.00K
Capex + Investments
Operating Cash Flow
€17.30 Million
EUR
Capital Expenditures
€230.00K
EUR
Medigene AG Cash Flow Reinvestment Rate (2011–2022)
Historical reinvestment intensity for Medigene AG across 2 annual periods. For the full cash flow conversion analysis, see Medigene AG (MDG1) cash flow conversion.
Annual Cash Flow Reinvestment Rate for Medigene AG (2011–2022)
Year-by-year capital reinvestment analysis for Medigene AG. See Medigene AG leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 1.09x | €13.01 Million | €11.98 Million | €1.01 Million | ▲ +1736.9% |
| 2011 | 0.06x | €406.00K | €6.86 Million | €406.00K | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow